General Information of Disease (ID: DIS51KH3)

Disease Name Radiation syndrome
Synonyms
Sicknesses, radiation; radiation syndrome; syndromes, radiation; radiation Sicknesses; radiation sickness; radiation syndromes; injury, radiation; syndrome, radiation; sickness, radiation; Injuries, radiation; radiation injury
Disease Class NF00: Radiation effect
Definition Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES.
Disease Hierarchy
DISKB4RK: Injury
DIS51KH3: Radiation syndrome
ICD Code
ICD-11
ICD-11: NF00
ICD-10
ICD-10: T66
ICD-9
ICD-9: 990
Expand ICD-11
'NF00
Expand ICD-10
'T66
Expand ICD-9
990

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 4 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Granexin gel DMZS2R7 Phase 3 NA [1]
Hexyl DMSXM7E Phase 3 Small molecular drug [2]
Entolimod DMMJXAR Phase 1 NA [3]
ON-01210.Na DMWYEDX Phase 1 Small molecular drug [4]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
QR-336 DMMWE2C Preclinical NA [5]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 2 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
EF-27 DMTJ7BP Terminated NA [6]
EUK-418 DMNOIWJ Terminated NA [7]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 5 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
AXP-107-17 DMCSJEU Investigative NA [8]
BIO-500 DM1S8KZ Investigative NA [8]
BP-C2 DMNO4YC Investigative NA [8]
CBLB-612 DMCFR8U Investigative NA [9]
Rx-101 DMO6E7B Investigative NA [8]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT00052637) Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer. U.S. National Institutes of Health.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020974)
5 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020574)
6 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005299)
7 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026284)
8 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
9 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1752).